Few topics in women's health generate as much confusion as hormone replacement therapy. Despite overwhelming evidence of its benefits when prescribed appropriately, many women remain unnecessarily fearful — often because of outdated information that has been comprehensively debunked by modern research.
Where did the fear come from?
The primary source of HRT anxiety is the Women's Health Initiative (WHI) study, published in 2002. The study suggested links between HRT and increased risks of breast cancer, heart disease, and stroke. The resulting media coverage was dramatic, and millions of women stopped HRT overnight.
What happened next is instructive: the original data was re-analysed, the study design was heavily critiqued, and subsequent research painted a far more nuanced picture. The WHI used older, less refined forms of HRT in a population of predominantly older women who were many years past menopause — a very different scenario from prescribing modern body-identical hormones to symptomatic women in their 40s and 50s.
What does the current evidence say?
- Cardiovascular health: When started within 10 years of menopause (the "window of opportunity"), HRT is associated with reduced cardiovascular risk, not increased.
- Breast cancer: The risk with combined HRT (oestrogen and progestogen) is small and comparable to the risk associated with drinking two glasses of wine per day or being overweight. Body-identical progesterone (micronised progesterone) carries a lower risk than older synthetic progestogens.
- Bone health: HRT is the most effective treatment for preventing osteoporotic fractures in postmenopausal women.
- Brain health: Emerging evidence suggests that timely HRT may have protective effects against cognitive decline, although more research is needed.
- Quality of life: For women with significant menopausal symptoms, HRT can be transformative — improving sleep, mood, energy, sexual function, and overall wellbeing.
Who should consider HRT?
HRT is appropriate for most women experiencing bothersome menopausal symptoms, particularly if they are under 60 or within 10 years of their last period. There are some absolute contraindications (such as a current hormone-sensitive cancer), but for the majority of women, the benefits outweigh the risks.
The decision to start HRT should be based on your individual symptoms, medical history, and risk profile — not on fear. A specialist consultation can help you weigh the evidence and make an informed choice.
Considering HRT? Get a personalised assessment from a menopause specialist.
Book Now